Tool
Stock screener
Filter the 3753 US stocks StockVane tracks, then sort by any column. Results carry the same Quant Rating shown on each stock’s page.
Top Quant-ratedLarge-cap dividend payersCheap & top-ratedBeaten-down (down 20%+ 1yr)High yield (4%+)Mega-cap winners
176 matches
| Company | 60d | Last | Chg% | Mkt cap | P/E | Yield | 1-yr | Quant ↓ |
|---|---|---|---|---|---|---|---|---|
| Adlai Nortye GroupANL | 8.55 | -5.63% | $550.60M | -- | -- | +533.3% | D 100 | |
| Climb BioCLYM | 9.19 | -0.97% | $539.80M | -- | -- | +440.6% | D 100 | |
| Nuvectis PharmaNVCT | 19.39 | -2.27% | $666.80M | -- | -- | +218.9% | C 100 | |
| ModernaMRNA | 195.00 | -2.17% | $78.90B | -- | -- | +722.1% | C 100 | |
| Spyre TherapeuticsSYRE | 93.47 | -4.26% | $8.88B | -- | -- | +285.3% | C 100 | |
| Kodiak SciencesKOD | 97.17 | -0.75% | $6.35B | -- | -- | +367.8% | C 100 | |
| Oruka TherapeuticsORKA | 95.81 | -1.80% | $6.50B | -- | -- | +227.1% | C 100 | |
| ErascaERAS | 13.61 | -4.29% | $4.78B | -- | -- | +366.1% | D 100 | |
| Sellas Life SciencesSLS | 13.66 | -8.08% | $2.78B | -- | -- | +792.8% | C 100 | |
| Korsana BiosciencesKRSA | 37.56 | +5.95% | $1.71B | -- | -- | +262.5% | C 100 | |
| LB PharmaceuticalsLBRX | 38.85 | -2.97% | $1.26B | 38.31 | -- | +153.4% | C 99 | |
| Silence TherapeuticsSLN | 19.81 | 0.00% | $1.23B | -- | -- | +213.9% | C 99 | |
| Vor BiopharmaVOR | 19.19 | +3.62% | $1.18B | 0.06 | -- | +157.6% | C 99 | |
| ImmunityBioIBRX | 6.02 | -8.37% | $6.40B | -- | -- | +189.4% | D 99 | |
| Definium TherapeuticsDFTX | 28.34 | -3.87% | $3.88B | -- | -- | +165.4% | D 99 | |
| AbCellera BiologicsABCL | 9.69 | -7.45% | $3.16B | -- | -- | +176.1% | C 99 | |
| Relay TherapeuticsRLAY | 16.12 | +1.32% | $3.56B | -- | -- | +138.1% | C 99 | |
| Tango TherapeuticsTNGX | 21.73 | -4.32% | $3.68B | -- | -- | +116.7% | D 99 | |
| Shattuck LabsSTTK | 4.46 | -1.98% | $454.22M | -- | -- | +119.7% | D 98 | |
| Enliven TherapeuticsELVN | 46.53 | +0.26% | $3.42B | -- | -- | +113.9% | C 98 | |
| ReplimuneREPL | 19.07 | -0.83% | $1.81B | -- | -- | +107.3% | C 98 | |
| Dianthus TherapeuticsDNTH | 84.55 | -0.33% | $4.76B | -- | -- | +104.0% | D 97 | |
| Maravai LifeSciencesMRVI | 6.98 | -2.92% | $1.04B | -- | -- | +86.1% | C 97 | |
| Roivant SciencesROIV | 38.66 | -0.78% | $28.01B | -- | -- | +91.2% | C 96 | |
| Fortrea HoldingsFTRE | 18.55 | -7.94% | $1.79B | -- | -- | +70.2% | C 96 | |
| AnaptysBioANAB | 46.63 | -1.62% | $1.39B | 8.98 | -- | +76.6% | D 96 | |
| Royalty PharmaRPRX | 68.45 | +1.08% | $30.48B | 44.74 | 1.35% | +78.9% | C 95 | |
| Kymera TherapeuticsKYMR | 115.31 | -3.42% | $9.84B | -- | -- | +74.6% | C 95 | |
| Edgewise TherapeuticsEWTX | 39.91 | -3.07% | $4.37B | 4.76 | -- | +76.0% | C 95 | |
| MBX BiosciencesMBX | 49.55 | -7.23% | $2.46B | -- | -- | +83.0% | C 95 | |
| GenmabGMAB | 50.60 | -1.46% | $31.20B | 43.25 | -- | +66.2% | C 92 | |
| SepternaSEPN | 38.61 | -1.51% | $1.84B | -- | -- | +51.1% | C 92 | |
| Alto NeuroscienceANRO | 25.37 | -4.30% | $1.02B | -- | -- | +91.5% | C 91 | |
| OmerosOMER | 13.21 | -5.71% | $983.66M | 8.52 | -- | +48.9% | D 91 | |
| Praxis Precision MedicinesPRAX | 300.43 | -3.37% | $8.40B | -- | -- | +76.9% | D 90 | |
| ExelixisEXEL | 64.63 | -1.82% | $15.77B | 19.35 | -- | +52.0% | C 89 | |
| Vir BiotechnologyVIR | 8.39 | -5.41% | $1.56B | -- | -- | +47.7% | D 89 | |
| Krystal BiotechKRYS | 308.89 | -2.19% | $9.15B | 41.97 | -- | +45.7% | D 88 | |
| VericelVCEL | 57.52 | -1.27% | $2.94B | 89.88 | -- | +45.3% | C 86 | |
| Palvella TherapeuticsPVLA | 142.85 | -2.00% | $2.09B | -- | -- | +51.8% | C 86 | |
| Puma BiotechnologyPBYI | 7.05 | -0.98% | $364.47M | 15.33 | -- | +44.2% | D 85 | |
| Protagonist TherapeuticsPTGX | 121.40 | -2.11% | $7.92B | 25.67 | -- | +42.2% | C 84 | |
| Aclaris TherapeuticsACRS | 3.44 | -1.71% | $545.63M | -- | -- | +37.1% | D 82 | |
| Ligand PharmaceuticalsLGND | 286.85 | -0.03% | $5.74B | 115.20 | -- | +44.0% | C 82 | |
| ImmunovantIMVT | 31.77 | -2.31% | $6.57B | -- | -- | +40.6% | D 81 | |
| Mirum PharmaceuticalsMIRM | 96.13 | +0.65% | $6.28B | -- | -- | +35.5% | D 80 | |
| Travere TherapeuticTVTX | 47.00 | -2.69% | $4.51B | -- | -- | +35.5% | D 77 | |
| Jazz PharmaceuticalsJAZZ | 230.26 | -2.62% | $14.78B | 68.12 | -- | +30.1% | C 76 | |
| Halozyme TherapeuticsHALO | 91.35 | -1.82% | $10.41B | 22.84 | -- | +29.9% | C 75 | |
| Aura BiosciencesAURA | 6.87 | -1.58% | $714.99M | -- | -- | +26.3% | C 73 | |
| PharvarisPHVS | 31.28 | -1.20% | $2.21B | -- | -- | +26.0% | D 73 | |
| Agios PharmaceuticalsAGIO | 27.60 | -4.03% | $1.65B | -- | -- | +9.4% | D 69 | |
| Design TherapeuticsDSGN | 9.02 | -3.22% | $577.61M | -- | -- | +8.0% | D 68 | |
| Jade BiosciencesJBIO | 15.31 | +1.66% | $1.06B | -- | -- | +27.6% | D 68 | |
| Vertex PharmaceuticalsVRTX | 515.02 | -1.08% | $130.58B | 33.14 | -- | +20.7% | C 68 | |
| NanobiotixNBTX | 26.50 | -2.98% | $1.35B | -- | -- | +26.6% | D 68 | |
| GH ResearchGHRS | 17.53 | -5.55% | $1.20B | -- | -- | +25.1% | D 67 | |
| Scholar RockSRRK | 48.13 | -4.45% | $5.87B | -- | -- | +19.7% | D 66 | |
| Trevi TherapeuticsTRVI | 13.35 | -2.70% | $1.90B | -- | -- | +21.5% | D 66 | |
| Intellia TherapeuticsNTLA | 10.00 | +5.04% | $1.40B | -- | -- | +21.8% | D 66 |
Reference only, not investment advice. A screen is a starting point, not a buy list. Quant Rating method: Data & Methodology.